This text is a result of machine translation.
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
Yaoming biological was included in the "unverified list" in the United States, and its share price plummeted
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM
How Malaysia Became Southeast Asia’s “Computing Power Hub”
Jan 07, 2026 12:24 PM
Consumer-Grade 3D Printing Going Global Is Reaching a Watershed
Dec 29, 2025 05:40 PM
Unpacking China | Key Chinese Firms to Watch This Week (14/12/2025-20/12/2025)
Dec 19, 2025 03:50 PM